Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion type Assertion NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_head.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion description "[The tumor hypoxia changes induced after bevacizumab treatment were evaluated using optical imaging with a HIF-1-dependent reporter gene using the NCI-H441 human lung adenocarcinoma xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_provenance.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion evidence source_evidence_literature NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_provenance.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion SIO_000772 19735869 NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_provenance.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion wasDerivedFrom befree-20140225 NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_provenance.
- NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_assertion wasGeneratedBy ECO_0000203 NP604527.RALv--eFc7Jlz2s5rYKEYJDrQ5fhv-iuvDBFa21-ERcHI130_provenance.